Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Schizophrenia Bulletin
|
February 28, 2014
Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery
James L Reilly, John A Sweeney
Addiction (Abingdon, England)
|
June 16, 2005
Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand
Chris Wilkins, James L Reilly, Sally Casswell
Drug and Alcohol Review
|
August 13, 2005
Estimating the dollar value of the illicit market for cannabis in New Zealand
Chris Wilkins, James L Reilly, Megan Pledger, et al.
Psychiatry Research. Neuroimaging
|
April 29, 2019
Circuit activity underlying a distinct modulator of prepulse inhibition
Linda Heidinger, James L Reilly, Lei Wang, et al.
Schizophrenia Research
|
November 11, 2019
The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia
Tatiana Karpouzian-Rogers, Jane Stocks, Herbert Y Meltzer, et al.
Schizophrenia Research
|
February 1, 2016
High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities
Tatiana M Karpouzian, Eva C Alden, James L Reilly, et al.
Schizophrenia Research
|
July 29, 2015
Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains
Eva C Alden, Derin J Cobia, James L Reilly, et al.
Biological Psychiatry
|
January 18, 2005
Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia
James L Reilly, Margret S H Harris, Matcheri S Keshavan, et al.
Psychological Medicine
|
January 4, 2006
Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia
Margret S H Harris, James L Reilly, Matcheri S Keshavan, et al.
Brain and Cognition
|
November 26, 2008
Pharmacological treatment effects on eye movement control
James L Reilly, Rebekka Lencer, Jeffrey R Bishop, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Schizophrenia Bulletin
|
February 28, 2014
Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery
James L Reilly, John A Sweeney
Addiction (Abingdon, England)
|
June 16, 2005
Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand
Chris Wilkins, James L Reilly, Sally Casswell
Drug and Alcohol Review
|
August 13, 2005
Estimating the dollar value of the illicit market for cannabis in New Zealand
Chris Wilkins, James L Reilly, Megan Pledger, et al.
Psychiatry Research. Neuroimaging
|
April 29, 2019
Circuit activity underlying a distinct modulator of prepulse inhibition
Linda Heidinger, James L Reilly, Lei Wang, et al.
Schizophrenia Research
|
November 11, 2019
The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia
Tatiana Karpouzian-Rogers, Jane Stocks, Herbert Y Meltzer, et al.
Schizophrenia Research
|
February 1, 2016
High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities
Tatiana M Karpouzian, Eva C Alden, James L Reilly, et al.
Schizophrenia Research
|
July 29, 2015
Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains
Eva C Alden, Derin J Cobia, James L Reilly, et al.
Biological Psychiatry
|
January 18, 2005
Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia
James L Reilly, Margret S H Harris, Matcheri S Keshavan, et al.
Psychological Medicine
|
January 4, 2006
Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia
Margret S H Harris, James L Reilly, Matcheri S Keshavan, et al.
Brain and Cognition
|
November 26, 2008
Pharmacological treatment effects on eye movement control
James L Reilly, Rebekka Lencer, Jeffrey R Bishop, et al.
Page
of 8